Compare FOSL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOSL | SENS |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.7M | 476.9M |
| IPO Year | 1994 | 2014 |
| Metric | FOSL | SENS |
|---|---|---|
| Price | $7.16 | $8.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $9.25 | ★ $13.67 |
| AVG Volume (30 Days) | ★ 733.7K | 670.0K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.26 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,004,406,000.00 | $16,389,000.00 |
| Revenue This Year | N/A | $82.21 |
| Revenue Next Year | $1.39 | $55.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $1.70 | $0.41 |
| 52 Week High | $7.33 | $10.64 |
| Indicator | FOSL | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 69.18 | 45.48 |
| Support Level | $3.74 | $8.45 |
| Resistance Level | $7.33 | $10.07 |
| Average True Range (ATR) | 0.38 | 0.47 |
| MACD | 0.05 | -0.18 |
| Stochastic Oscillator | 88.98 | 16.13 |
Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.